146 related articles for article (PubMed ID: 34634897)
1. Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients.
Ora J; Coppola A; Perduno A; Manzetti GM; Puxeddu E; Rogliani P
Monaldi Arch Chest Dis; 2021 Oct; 92(2):. PubMed ID: 34634897
[TBL] [Abstract][Full Text] [Related]
2. The impact of carrying supplemental oxygen on exercise capacity and dyspnea in patients with interstitial lung disease.
Ramadurai D; Riordan M; Graney B; Churney T; Olson AL; Swigris JJ
Respir Med; 2018 May; 138():32-37. PubMed ID: 29724390
[TBL] [Abstract][Full Text] [Related]
3. [Acute effects of oxygen on dyspnea and exercise tolerance in patients with pulmonary emphysema with only mild exercise-induced oxyhemoglobin desaturation].
Matsuzawa Y; Kubo K; Fujimoto K; Eda S; Yamaguchi S; Koizumi T; Kobayashi T
Nihon Kokyuki Gakkai Zasshi; 2000 Nov; 38(11):831-5. PubMed ID: 11193316
[TBL] [Abstract][Full Text] [Related]
4. The effect of domiciliary high flow nasal cannula treatment on dyspnea and walking distance in patients with interstitial lung disease - A pilot study.
Weinreich UM; Burchardt C; Huremovic J
Chron Respir Dis; 2022; 19():14799731221137085. PubMed ID: 36366859
[TBL] [Abstract][Full Text] [Related]
5. Supplemental oxygen for the management of dyspnea in interstitial lung disease.
Schaeffer MR; Molgat-Seon Y; Ryerson CJ; Guenette JA
Curr Opin Support Palliat Care; 2019 Sep; 13(3):174-178. PubMed ID: 31145136
[TBL] [Abstract][Full Text] [Related]
6. The effect of heated humidified nasal high flow oxygen supply on exercise tolerance in patients with interstitial lung disease: A pilot study.
Al Chikhanie Y; Veale D; Verges S; Hérengt F
Respir Med; 2021 Sep; 186():106523. PubMed ID: 34225230
[TBL] [Abstract][Full Text] [Related]
7. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
8. A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with Interstitial Lung Disease.
Edvardsen A; Jarosch I; Grongstad A; Wiegand L; Gloeckl R; Kenn K; Spruit MA
PLoS One; 2018; 13(12):e0209069. PubMed ID: 30592724
[TBL] [Abstract][Full Text] [Related]
9. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD.
Díaz AA; Morales A; Díaz JC; Ramos C; Klaassen J; Saldías F; Aravena C; Díaz R; Lisboa C; Washko GR; Díaz O
Respir Med; 2013 Apr; 107(4):570-9. PubMed ID: 23313036
[TBL] [Abstract][Full Text] [Related]
10. Effects of walking with a portable oxygen concentrator on muscle oxygenation while performing normal or pursed-lip breathing in patients with interstitial lung disease: a randomized crossover trial.
Hun Kim S; Beom Shin Y; Shin MJ; Hui Hong C; Huh S; Yoo W; Lee K
Ther Adv Respir Dis; 2023; 17():17534666231186732. PubMed ID: 37462163
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success.
Brunetti G; Malovini A; Maniscalco M; Balestrino A; Carone M; Visca D; Capelli A; Vitacca M; Bellazzi R; Piaggi G; Fuschillo S; Aliani M; Spanevello A; Prince I; Paneroni M; Ambrosino N
Respir Med; 2021; 185():106473. PubMed ID: 34038844
[TBL] [Abstract][Full Text] [Related]
12. A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD.
Ora J; Calzetta L; Pezzuto G; Senis L; Paone G; Mari A; Portalone S; Rogliani P; Puxeddu E; Saltini C
Respir Med; 2013 Dec; 107(12):2014-21. PubMed ID: 24161677
[TBL] [Abstract][Full Text] [Related]
13. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
[TBL] [Abstract][Full Text] [Related]
14. Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease.
Jenkins S; Čečins N
Intern Med J; 2011 May; 41(5):416-22. PubMed ID: 20059599
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute oxygen supplementation on functional capacity and heart rate recovery in Eisenmenger syndrome.
Gonzaga LR; Matos-Garcia BC; Rocco IS; Begot I; Bolzan DW; Tatani SB; Santos VB; Silva CM; Carvalho AC; Arena R; Gomes WJ; Guizilini S
Int J Cardiol; 2017 Mar; 231():110-114. PubMed ID: 28082094
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory Oxygen in Fibrotic Interstitial Lung Disease: A Pilot, Randomized, Triple-Blinded, Sham-Controlled Trial.
Khor YH; Holland AE; Goh NSL; Miller BR; Vlahos R; Bozinovski S; Lahham A; Glaspole I; McDonald CF
Chest; 2020 Jul; 158(1):234-244. PubMed ID: 32113924
[TBL] [Abstract][Full Text] [Related]
17. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
[TBL] [Abstract][Full Text] [Related]
18. Oxygen improves maximal exercise performance in interstitial lung disease.
Harris-Eze AO; Sridhar G; Clemens RE; Gallagher CG; Marciniuk DD
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1616-22. PubMed ID: 7952624
[TBL] [Abstract][Full Text] [Related]
19. Effects of 100 % oxygen during exercise in patients with interstitial lung disease.
Cournoyer J; Ramos CF; Sturgill B; Tang F; DeLuca N; Mirsaeidi M; Jackson RM
Respir Physiol Neurobiol; 2020 Mar; 274():103367. PubMed ID: 31911201
[TBL] [Abstract][Full Text] [Related]
20. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia.
Dean NC; Brown JK; Himelman RB; Doherty JJ; Gold WM; Stulbarg MS
Am Rev Respir Dis; 1992 Oct; 146(4):941-5. PubMed ID: 1416422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
